ABOS Long Call Strategy

ABOS (Acumen Pharmaceuticals, Inc.), in the Healthcare sector, (Biotechnology industry), listed on NASDAQ.

Acumen Pharmaceuticals Inc. operates as a biopharmaceutical entity in the clinical development stage, dedicated to discovering and advancing therapeutic solutions for Alzheimer's disease. A key focus for the company involves progressing ACU193, an investigational targeted immunotherapy drug candidate. This particular humanized monoclonal antibody is currently undergoing initial human testing in Phase I clinical trials, where it is designed to specifically target soluble amyloid-beta oligomers. The firm was established in 1996 and maintains its principal headquarters in Charlottesville, Virginia.

ABOS (Acumen Pharmaceuticals, Inc.) trades in the Healthcare sector, specifically Biotechnology, with a market capitalization of approximately $181.3M, a beta of 0.33 versus the broader market, a 52-week range of 1.21-3.6, average daily share volume of 434K, a public-listing history dating back to 2021, approximately 61 full-time employees. These structural characteristics shape how ABOS stock options price implied volatility around earnings windows, capital events, and macro-driven sector rotations.

A beta of 0.33 indicates ABOS has historically moved less than the broader market, dampening realized volatility and producing tighter expected-move bands per unit of dollar exposure.

What is a long call on ABOS?

A long call buys upside exposure with a fixed maximum loss equal to the premium paid; profit accrues if the underlying closes above the strike plus premium at expiration.

ABOS snapshot

As of August 14, 2026, spot at $2.68, ATM IV 85.80%, IV rank 15.82%, expected move 24.60%. The long call on ABOS below is built from the end-of-day chain, with strikes snapped to listed contracts and premiums pulled from the bid/ask midpoint at a 35-day expiry.

Why this long call structure on ABOS specifically: ABOS IV at 85.80% is on the cheap side of its 1-year range, which favors premium-buying structures like a ABOS long call, with a market-implied 1-standard-deviation move of approximately 24.60% (roughly $0.66 on the underlying). The 35-day window matched to the front-month expiry keeps theta exposure bounded while still capturing the post-snapshot move; longer-dated ABOS expiries trade a higher absolute premium for lower per-day decay. Position sizing on ABOS should anchor to the underlying notional of $2.68 per share and to the trader's directional view on ABOS stock.

ABOS long call setup

The ABOS long call below is built from the end-of-day chain, with each option leg priced at the bid/ask midpoint of its listed strike. With ABOS at $2.68 on that close, the first option leg uses a $2.68 strike; additional legs (when the strategy has them) anchor to spot-relative offsets. Premiums come from the bid/ask midpoint on the listed ABOS chain at a 35-day expiry; the cross-strike IV skew is reflected directly in the per-leg values rather than approximated. Quantity sizing assumes one contract per option leg (or 100 ABOS shares for the stock leg in covered calls and collars).

ActionTypeStrike / BasisPremium (est)
Buy 1Call$2.68N/A

ABOS long call risk and reward

Net Premium / Debit
N/A
Max Profit (per contract)
Unbounded
Max Loss (per contract)
Unbounded
Breakeven(s)
None on modeled curve
Risk / Reward Ratio
N/A

Max profit is unbounded; max loss equals the premium paid times 100. Breakeven is strike plus premium.

ABOS long call payoff curve

Modeled P&L at expiration across a range of underlying prices for the long call on ABOS. Each row is one sampled price point from the computed payoff curve; the full curve uses 200 price points internally before being summarized into 10 rows here.

When traders use long call on ABOS

Long calls on ABOS express a bullish thesis with defined risk; traders use them ahead of ABOS catalysts (earnings, product launches, macro events) when the expected upside justifies the premium and theta decay.

ABOS thesis for this long call

The market-implied 1-standard-deviation range for ABOS extends from approximately $2.02 on the downside to $3.34 on the upside. A ABOS long call expresses a directional view that the underlying closes above the strike plus premium at expiration, ideally with implied volatility holding or expanding to preserve extrinsic value through the hold period. Current ABOS IV rank near 15.82% sits in the lower third of its 1-year distribution, where IV often re-expands toward the mean; this favors premium-buying structures and disadvantages premium-selling structures on ABOS at 85.80%. As a Healthcare name, ABOS options can move on sector-level news flow (peer earnings, regulatory updates, industry-specific macro data) in addition to ABOS-specific events.

ABOS long call positions are structurally bullish; the modeled P&L assumes European-style exercise at expiration and ignores early assignment, transaction costs, dividends paid before expiry on the stock leg (when present), and the bid-ask spread on the listed chain. ABOS positions also carry Healthcare sector concentration risk; news flow inside the sector (peer earnings, regulatory shifts, supply-chain headlines) can move ABOS alongside the broader basket even when ABOS-specific fundamentals are unchanged. Long-premium structures like a long call on ABOS are particularly exposed to IV-crush risk through scheduled events (earnings, FDA decisions, central-bank meetings) where IV typically contracts post-event regardless of the directional outcome. Always rebuild the position from current ABOS chain quotes before placing a trade.

Frequently asked questions

What is a long call on ABOS?
A long call on ABOS is the long call strategy applied to ABOS (stock). The strategy is structurally bullish: A long call buys upside exposure with a fixed maximum loss equal to the premium paid; profit accrues if the underlying closes above the strike plus premium at expiration. With ABOS stock at $2.68 on the most recent close, the strikes shown on this page are snapped to the nearest listed ABOS chain strike and the premiums come straight from that session's bid/ask midpoint.
How are ABOS long call max profit and max loss calculated?
Max profit is unbounded; max loss equals the premium paid times 100. Breakeven is strike plus premium. For the ABOS long call priced from the end-of-day chain at a 30-day expiry (ATM IV 85.80%), the computed maximum profit is unbounded per contract and the computed maximum loss is unbounded per contract. Live intraday quotes will differ as the chain moves through the trading session.
What is the breakeven for a ABOS long call?
The breakeven for the ABOS long call priced on this page is no defined breakeven on the modeled curve at expiration, derived from the end-of-day chain's premiums. Breakeven is the underlying price at which the strategy's P&L crosses zero ignoring transaction costs and assignment risk. The ABOS market-implied 1-standard-deviation expected move in the same options snapshot is approximately 24.60%; if the move sits well outside the breakeven distance, the structure's risk-reward becomes correspondingly tighter.
When should you consider a long call on ABOS?
Long calls on ABOS express a bullish thesis with defined risk; traders use them ahead of ABOS catalysts (earnings, product launches, macro events) when the expected upside justifies the premium and theta decay.
How does current ABOS implied volatility affect this long call?
ABOS ATM IV is at 85.80% with IV rank near 15.82%, which is on the low end of its 1-year range. Premium-buying structures (long call, long put, debit spreads) are relatively cheap in this regime; premium-selling structures collect less credit per unit risk.

Related ABOS analysis